日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Self-assembled PEGylated nanoparticles based on Elafibranor derivative 3d for the treatment of metabolic dysfunction-associated steatohepatitis

基于Elafibranor衍生物3d的自组装PEG化纳米粒子用于治疗代谢功能障碍相关性脂肪性肝炎

Yu, Jiajia; Wang, Jiawen; Li, Shuhan; Bai, Sule; Wang, Xi; Ban, Yuxuan; Zhang, Shouqing; Yu, Yue; Liu, Jiang; Liu, Zhen; Galons, Herve; Zhang, Yongmin; Yu, Peng; Xiang, Cen; Teng, Yuou

Novel Aurone Derivative Ameliorates MASH Lipid Metabolism via the AMPK-ACC-PPARα Axis

新型奥罗酮衍生物通过AMPK-ACC-PPARα轴改善MASH脂质代谢

Bai, Sule; Zou, Yi; Zhang, Wenyi; Yu, Jiajia; Qie, Zhenzhen; Liu, Zhen; Yu, Peng; Xiang, Cen; Teng, Yuou

Compound 3d Attenuates Metabolic Dysfunction-Associated Steatohepatitis via Peroxisome Proliferator-Activated Receptor Pathway Activation and Inhibition of Inflammatory and Apoptotic Signaling.

化合物 3d 通过过氧化物酶体增殖物激活受体通路激活和炎症及凋亡信号抑制来减轻代谢功能障碍相关的脂肪性肝炎

Zhang Shouqing, Yu Jiajia, Bai Sule, Li Shuhan, Qiu Quanyuan, Kong Xiangshun, Xiang Cen, Liu Zhen, Yu Peng, Teng Yuou